Published in Biomacromolecules on May 13, 2003
Peptide-based Biopolymers in Biomedicine and Biotechnology. Mater Sci Eng R Rep (2008) 1.25
Tunable self-assembly of genetically engineered silk--elastin-like protein polymers. Biomacromolecules (2011) 1.23
Biomaterials for vascular tissue engineering. Regen Med (2010) 1.19
Peptide-directed self-assembly of hydrogels. Acta Biomater (2008) 1.15
Protein-based block copolymers. Biomacromolecules (2011) 1.11
Deformation responses of a physically cross-linked high molecular weight elastin-like protein polymer. Biomacromolecules (2008) 1.07
A review of combined experimental and computational procedures for assessing biopolymer structure-process-property relationships. Biomaterials (2012) 1.06
Conformational behavior of chemically reactive alanine-rich repetitive protein polymers. Biomacromolecules (2005) 1.05
Smart self-assembled hybrid hydrogel biomaterials. Angew Chem Int Ed Engl (2012) 1.03
Surface Induced nanofiber growth by self-assembly of a silk-elastin-like protein polymer. Langmuir (2009) 0.98
Characterization and real-time imaging of gene expression of adenovirus embedded silk-elastinlike protein polymer hydrogels. Mol Pharm (2008) 0.96
Retracted Fabrication of highly uniform nanoparticles from recombinant silk-elastin-like protein polymers for therapeutic agent delivery. ACS Nano (2011) 0.93
Influence of polymer structure and biodegradation on DNA release from silk-elastinlike protein polymer hydrogels. Int J Pharm (2008) 0.92
Silk-elastin-like protein biomaterials for the controlled delivery of therapeutics. Expert Opin Drug Deliv (2014) 0.84
High level expression and facile purification of recombinant silk-elastin-like polymers in auto induction shake flask cultures. AMB Express (2013) 0.79
High Throughput Screening of Dynamic Silk-Elastin-Like Protein Biomaterials. Adv Funct Mater (2014) 0.78
Fabricated Elastin. Adv Healthc Mater (2015) 0.76
Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates. J Nucl Med (2005) 2.09
In vitro and in vivo evaluation of recombinant silk-elastinlike hydrogels for cancer gene therapy. J Control Release (2004) 1.53
Transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers: Influence of size, charge and fluorescent labeling. Pharm Res (2006) 1.51
Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano (2011) 1.47
Genetically engineered silk-elastinlike protein polymers for controlled drug delivery. Adv Drug Deliv Rev (2002) 1.46
Cellular uptake and toxicity of gold nanoparticles in prostate cancer cells: a comparative study of rods and spheres. J Appl Toxicol (2010) 1.38
Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability. Bioconjug Chem (2007) 1.36
Swelling behavior of a genetically engineered silk-elastinlike protein polymer hydrogel. Biomaterials (2002) 1.36
Complete recombinant silk-elastinlike protein-based tissue scaffold. Biomacromolecules (2010) 1.30
Cellular uptake and cytotoxicity of silica nanotubes. Nano Lett (2008) 1.27
Endocytosis and interaction of poly (amidoamine) dendrimers with Caco-2 cells. Pharm Res (2007) 1.25
Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers. J Control Release (2002) 1.23
Transepithelial and endothelial transport of poly (amidoamine) dendrimers. Adv Drug Deliv Rev (2005) 1.23
Endocytosis inhibitors prevent poly(amidoamine) dendrimer internalization and permeability across Caco-2 cells. Mol Pharm (2008) 1.21
In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics. J Control Release (2012) 1.21
Nanocarriers for nuclear imaging and radiotherapy of cancer. Curr Pharm Des (2006) 1.20
Molecular engineering of silk-elastinlike polymers for matrix-mediated gene delivery: biosynthesis and characterization. Mol Pharm (2005) 1.18
Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles. Nanotoxicology (2011) 1.17
Targeting tumor angiogenic vasculature using polymer-RGD conjugates. J Control Release (2005) 1.17
Genetically engineered polymers: status and prospects for controlled release. J Control Release (2004) 1.16
Silk-elastinlike recombinant polymers for gene therapy of head and neck cancer: from molecular definition to controlled gene expression. J Control Release (2009) 1.15
Recombinant silk-elastinlike protein polymer displays elasticity comparable to elastin. Biomacromolecules (2009) 1.13
Solute diffusion in genetically engineered silk-elastinlike protein polymer hydrogels. J Control Release (2002) 1.13
Controlled release of plasmid DNA from a genetically engineered silk-elastinlike hydrogel. Pharm Res (2002) 1.11
Silk-elastinlike protein polymers for matrix-mediated cancer gene therapy. Adv Drug Deliv Rev (2010) 1.10
Wet-spinning of recombinant silk-elastin-like protein polymer fibers with high tensile strength and high deformability. Biomacromolecules (2009) 1.06
Polymeric conjugates for drug delivery. Chem Mater (2012) 1.06
Guided Delivery of Polymer Therapeutics Using Plasmonic Photothermal Therapy. Nano Today (2012) 1.05
Cellular entry of G3.5 poly (amido amine) dendrimers by clathrin- and dynamin-dependent endocytosis promotes tight junctional opening in intestinal epithelia. Pharm Res (2010) 1.04
Polymeric conjugates of mono- and bi-cyclic alphaVbeta3 binding peptides for tumor targeting. J Control Release (2006) 1.04
Potential oral delivery of 7-ethyl-10-hydroxy-camptothecin (SN-38) using poly(amidoamine) dendrimers. Pharm Res (2008) 1.01
Randomized Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration With and Without Rapid On-site Evaluation for Lung Cancer Genotyping. Chest (2015) 1.00
Transepithelial transport of PEGylated anionic poly(amidoamine) dendrimers: implications for oral drug delivery. J Control Release (2009) 1.00
Technetium-99m-Labeled N-(2-hydroxypropyl) methacrylamide copolymers: synthesis, characterization, and in vivo biodistribution. Pharm Res (2004) 0.99
Cationic PAMAM dendrimers aggressively initiate blood clot formation. ACS Nano (2012) 0.99
Surface Induced nanofiber growth by self-assembly of a silk-elastin-like protein polymer. Langmuir (2009) 0.98
HPMA copolymer-cyclic RGD conjugates for tumor targeting. Adv Drug Deliv Rev (2009) 0.98
Silk-elastinlike protein polymer hydrogels for localized adenoviral gene therapy of head and neck tumors. Biomacromolecules (2009) 0.98
Influence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity: their vasculature effect and tolerance threshold. ACS Nano (2012) 0.97
Characterization and real-time imaging of gene expression of adenovirus embedded silk-elastinlike protein polymer hydrogels. Mol Pharm (2008) 0.96
Autoclaving as a chemical-free process to stabilize recombinant silk-elastinlike protein polymer nanofibers. Appl Phys Lett (2011) 0.96
Recombinant protein-based polymers for advanced drug delivery. Chem Soc Rev (2012) 0.96
Polymer-peptide conjugates for angiogenesis targeted tumor radiotherapy. Nucl Med Biol (2006) 0.96
Genetic synthesis and characterization of pH- and temperature-sensitive silk-elastinlike protein block copolymers. J Biomed Mater Res (2002) 0.95
In vitro chondrogenesis of mesenchymal stem cells in recombinant silk-elastinlike hydrogels. Pharm Res (2007) 0.94
Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment. J Drug Target (2011) 0.94
Charge affects the oral toxicity of poly(amidoamine) dendrimers. Eur J Pharm Biopharm (2013) 0.93
Template synthesis of multifunctional nanotubes for controlled release. J Control Release (2006) 0.93
Tumor-targeted HPMA copolymer-(RGDfK)-(CHX-A''-DTPA) conjugates show increased kidney accumulation. J Control Release (2008) 0.93
Retracted Fabrication of highly uniform nanoparticles from recombinant silk-elastin-like protein polymers for therapeutic agent delivery. ACS Nano (2011) 0.93
Nanoparticle geometry and surface orientation influence mode of cellular uptake. ACS Nano (2013) 0.93
G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity. J Control Release (2010) 0.93
Influence of polymer structure and biodegradation on DNA release from silk-elastinlike protein polymer hydrogels. Int J Pharm (2008) 0.92
Silk-elastin-like hydrogel improves the safety of adenovirus-mediated gene-directed enzyme-prodrug therapy. Mol Pharm (2010) 0.92
Carboxyl-terminated PAMAM-SN38 conjugates: synthesis, characterization, and in vitro evaluation. Bioconjug Chem (2010) 0.91
Noninvasive monitoring of HPMA copolymer-RGDfK conjugates by magnetic resonance imaging. Pharm Res (2009) 0.91
Comparison of silk-elastinlike protein polymer hydrogel and poloxamer in matrix-mediated gene delivery. Int J Pharm (2011) 0.91
Cationic PAMAM dendrimers disrupt key platelet functions. Mol Pharm (2012) 0.90
Influence of solute charge and hydrophobicity on partitioning and diffusion in a genetically engineered silk-elastin-like protein polymer hydrogel. Macromol Biosci (2010) 0.90
Silk-elastinlike protein polymers improve the efficacy of adenovirus thymidine kinase enzyme prodrug therapy of head and neck tumors. J Gene Med (2010) 0.90
A prostate-specific antigen activated N-(2-hydroxypropyl) methacrylamide copolymer prodrug as dual-targeted therapy for prostate cancer. Mol Cancer Ther (2007) 0.90
PAMAM-camptothecin conjugate inhibits proliferation and induces nuclear fragmentation in colorectal carcinoma cells. Pharm Res (2010) 0.89
Targetable water-soluble polymer-drug conjugates for the treatment of visceral leishmaniasis. J Control Release (2004) 0.89
Synthesis and characterization of a matrix-metalloproteinase responsive silk-elastinlike protein polymer. Biomacromolecules (2013) 0.88
Gold nanorod mediated plasmonic photothermal therapy: a tool to enhance macromolecular delivery. Int J Pharm (2011) 0.88
Nanomechanical stimulus accelerates and directs the self-assembly of silk-elastin-like nanofibers. J Am Chem Soc (2011) 0.88
Biodistribution of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer drug delivery. Mol Pharm (2009) 0.88
Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck. J Drug Target (2005) 0.87
Silica nanoconstruct cellular toleration threshold in vitro. J Control Release (2011) 0.87
Optically transparent recombinant silk-elastinlike protein polymer films. J Phys Chem B (2011) 0.87
HPMA copolymer-aminohexylgeldanamycin conjugates targeting cell surface expressed GRP78 in prostate cancer. Pharm Res (2010) 0.85
Macrophage targeted N-(2-hydroxypropyl)methacrylamide conjugates for magnetic resonance imaging. Mol Pharm (2006) 0.85
Comparison of active and passive targeting of docetaxel for prostate cancer therapy by HPMA copolymer-RGDfK conjugates. Mol Pharm (2011) 0.85
Synergistic enhancement of cancer therapy using a combination of heat shock protein targeted HPMA copolymer-drug conjugates and gold nanorod induced hyperthermia. J Control Release (2013) 0.85